DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Gulia S, Kannan S, Badwe R, Gupta S.
Evaluation of 1-year vs shorter durations of adjuvant trastuzumab among patients with early breast cancer: an individual participant data and trial-level meta-analysis.
JAMA Netw Open 2020;
3 (08) e2011777
We do not assume any responsibility for the contents of the web pages of other providers.